You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The new company will develop microbiome diagnostics for multiple indications including inflammatory bowel disease and liver disorders.
The companies will discover and develop microbiome-derived biomarkers, drug targets, and bioactive molecules for cancer.
AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
Time magazine looks into how liquid biopsies are changing cancer care.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.